Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients

Author： Strollo Felice  

Publisher： Informa Healthcare

ISSN： 1473-0790

Source： The Aging Male, Vol.16, Iss.2, 2013-06, pp. : 33-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men

By Angelova Petya  

The Aging Male, Vol. 15, Iss. 3, 2012-09 ,pp. : 173-179

Informa Healthcare

Access to resources Recommend Favorite

Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy

By Taniguchi Hisanori   Kawa Gen   Kinoshita Hidefumi   Matsuda Tadashi  

The Aging Male, Vol. 14, Iss. 3, 2011-09 ,pp. : 190-194

Informa Healthcare

Access to resources Recommend Favorite

Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients

By Amano Toshiyasu   Imao Tetsuya   Takemae Katsurou   Iwamoto Teruaki   Nakanome Mariko  

The Aging Male, Vol. 13, Iss. 4, 2010-12 ,pp. : 242-246

Informa Healthcare

Access to resources Recommend Favorite

A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease

By Tan R. S.   Pu S. J.  

The Aging Male, Vol. 6, Iss. 1, 2003-03 ,pp. : 13-17

Informa Healthcare

Access to resources Recommend Favorite

Testosterone replacement therapy and cardiovascular risk factors modification

By Chahla Elie J.   Hayek Mireille El   Morley John E.  

The Aging Male, Vol. 14, Iss. 2, 2011-06 ,pp. : 83-90

Informa Healthcare

Access to resources Recommend Favorite